Showing results (31-40 of 38) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 38 results.
Clinical Journal of Gastroenterology|July 17, 2015
Extensive 0-IIc (undifferentiated carcinoma) lesion around a gastric adenoma: a case reportYusuke Horiuchi, Junko Fujisaki, Tomoki Shimizu, et al.
Japanese Journal of Cancer Research : Gann|October 3, 2002
U-shaped effect of drinking and linear effect of smoking on risk for stomach cancer in JapanShogo Kikuchi, Toshifusa Nakajima, Osamu Kobayashi, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|September 5, 2015
A multicenter phase II study of preoperative chemoradiotherapy with S-1 plus oxaliplatin for locally advanced rectal cancer (SHOGUN trial)Satoshi Matsusaka, Soichiro Ishihara, Keisaku Kondo, et al.
Cancer Chemotherapy and Pharmacology|January 18, 2012
Randomized phase II study of gemcitabine and S-1 combination versus gemcitabine alone in the treatment of unresectable advanced pancreatic cancer (Japan Clinical Cancer Research Organization PC-01 study)Masato Ozaka, Yuji Matsumura, Hiroshi Ishii, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|April 22, 2019
Long-term results of a multicenter phase II study of preoperative chemoradiotherapy with S-1 plus oxaliplatin for locally advanced rectal cancer (JACCRO CC-04: SHOGUN Trial)Keisaku Kondo, Satoshi Matsusaka, Soichiro Ishihara, et al.
Radiation Oncology (London, England)|January 24, 2015
A phase I dose escalation study of oxaliplatin plus oral S-1 and pelvic radiation in patients with locally advanced rectal cancer (SHOGUN trial)Soichiro Ishihara, Satoshi Matsusaka, Keisaku Kondo, et al.
Journal of Cancer Research and Clinical Oncology|December 25, 2013
Addition of docetaxel to S-1 without platinum prolongs survival of patients with advanced gastric cancer: a randomized study (START)Wasaburo Koizumi, Yeul Hong Kim, Masashi Fujii, et al.
Cancer Biology & Therapy|April 23, 2016
Combined assessment of EGFR-related molecules to predict outcome of 1st-line cetuximab-containing chemotherapy for metastatic colorectal cancerYu Sunakawa, Dongyun Yang, Miriana Moran, et al.
Pageof 4